Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer (vol 510, pg 407, 2014)

被引:3
|
作者
Ali, Khaled
Soond, Dalya R.
Pineiro, Roberto
Hagemann, Thorsten
Pearce, Wayne
Lim, Ee Lyn
Bouabe, Hicham
Scudamore, Cheryl L.
Hancox, Timothy
Maecker, Heather
Friedman, Lori
Turner, Martin
Okkenhaug, Klaus
Vanhaesebroeck, Bart
机构
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1038/nature17641
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nature 510, 407–411 (2014); doi:10.1038/nature13444 Queen Mary University London notified Nature and University College London that there is reason to question the provenance of the data for Fig. 5b, d, e of this Letter (Fig. 5a, c data are unaffected). Ongoing studies are investigating the reportedeffect of p110δ inhibition in the pancreatic cancer mouse model.
引用
收藏
页码:580 / 580
页数:1
相关论文
共 50 条
  • [1] Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
    Ali, Khaled
    Soond, Dalya R.
    Pineiro, Roberto
    Hagemann, Thorsten
    Pearce, Wayne
    Lim, Ee Lyn
    Bouabe, Hicham
    Scudamore, Cheryl L.
    Hancox, Timothy
    Maecker, Heather
    Friedman, Lori
    Turner, Martin
    Okkenhaug, Klaus
    Vanhaesebroeck, Bart
    [J]. NATURE, 2014, 510 (7505) : 407 - +
  • [2] Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
    Khaled Ali
    Dalya R. Soond
    Roberto Piñeiro
    Thorsten Hagemann
    Wayne Pearce
    Ee Lyn Lim
    Hicham Bouabe
    Cheryl L. Scudamore
    Timothy Hancox
    Heather Maecker
    Lori Friedman
    Martin Turner
    Klaus Okkenhaug
    Bart Vanhaesebroeck
    [J]. Nature, 2014, 510 : 407 - 411
  • [3] Correction: Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
    Khaled Ali
    Dalya R. Soond
    Roberto Piñeiro
    Thorsten Hagemann
    Wayne Pearce
    Ee Lyn Lim
    Hicham Bouabe
    Cheryl L. Scudamore
    Timothy Hancox
    Heather Maecker
    Lori Friedman
    Martin Turner
    Klaus Okkenhaug
    Bart Vanhaesebroeck
    [J]. Nature, 2016, 535 : 580 - 580
  • [4] The PI3Ks p110α and p110δ control regulatory T cell function
    Slack, E. C. M.
    Soond, D. R.
    Scudamore, C. L.
    Garden, O. A.
    Okkenhaug, K.
    [J]. IMMUNOLOGY, 2011, 135 : 54 - 54
  • [5] PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression
    Dong, Shuai
    Harrington, Bonnie K.
    Hu, Eileen Y.
    Greene, Joseph T.
    Lehman, Amy M.
    Minh Tran
    Wasmuth, Ronni L.
    Long, Meixiao
    Muthusamy, Natarajan
    Brown, Jennifer R.
    Johnson, Amy J.
    Byrd, John C.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (01): : 122 - 136
  • [6] PI3K p110δ controls the differentiation and function of regulatory T cells
    Patton, D. T.
    Emery, J. L.
    Rowan, W. C.
    Okkenhaug, K.
    [J]. IMMUNOLOGY, 2008, 125 : 129 - 129
  • [7] The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function
    Chellappa, Stalin
    Kushekhar, Kushi
    Munthe, Ludvig A.
    Tjonnfjord, Geir E.
    Aandahl, Einar M.
    Okkenhaug, Klaus
    Tasken, Kjetil
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (05): : 1397 - 1405
  • [8] The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
    Zhang, Lei
    Li, Yidong
    Wang, Qianchao
    Chen, Zhuo
    Li, Xiaoyun
    Wu, Zhuoxun
    Hu, Chaohua
    Liao, Dan
    Zhang, Wei
    Chen, Zhe-Sheng
    [J]. MOLECULAR CANCER, 2020, 19 (01)
  • [9] The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
    Lei Zhang
    Yidong Li
    Qianchao Wang
    Zhuo Chen
    Xiaoyun Li
    Zhuoxun Wu
    Chaohua Hu
    Dan Liao
    Wei Zhang
    Zhe-Sheng Chen
    [J]. Molecular Cancer, 19
  • [10] The PI3K p110δ Regulates Expression of CD38 on Regulatory T Cells
    Patton, Daniel T.
    Wilson, Marcus D.
    Rowan, Wendy C.
    Soond, Dalya R.
    Okkenhaug, Klaus
    [J]. PLOS ONE, 2011, 6 (03):